Form D · Biotechnology

Lifeline Biotechnologies, Inc.

Reno, NV · CIK 0000932276

Offering snapshot reported Nov 4, 2009 · SEC filing

Reported sold
$200K
Offering amount: $750K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 28, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 4, 2009Initial$200,000No comparison1SEC filing
Jan 9, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jan 5, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Oct 9, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Aug 13, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jul 17, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jun 6, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Apr 21, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
04.3
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-93227-6C

Source: Form D, filed Nov 4, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jim Holmes Director, Executive
Louis Keith Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1325 Airmotive Way Suite 175
Reno, NV, 89592